Literature DB >> 9719366

Bony orbital morphology in neurofibromatosis type 1 (NF1).

S C Kaste1, E K Pivnick.   

Abstract

We retrospectively compared patients with NF1 with and without optic pathway gliomas (OPG) to determine the incidence and range of orbital developmental abnormalities and compared the incidence of OPG in African-Americans and whites. From cranial MR scans, we manually measured 14 orbital dimensions, compared them to published standards of Waitzman et al, calculated orbital volumes, and determined the presence or absence of volumetric symmetry (delta v) (delta v < or = 3 cm3 was considered to be symmetrical). We compared the results of orbital configurational assessment between patients with (group I) and those without OPG (group II). The study population comprised 58 patients, 24 boys, 18 African-American, and one Hispanic. Median age at imaging was 7 years (range 0.5-25.5 years). Fifty-eight percent had conformational abnormalities, 16 of whom had more than one abnormality (28%), the most frequent being increased intertemporal distance (n=10), increased lateral orbital distance (n=8), increased medial wall length (n=6), and decreased medial wall length (n=6). The increased intertemporal and lateral orbital distances may contribute to the appearance of hypertelorism. Only two patients had sphenoid wing hypoplasia. We found a high incidence of orbital dimensional abnormalities in the total population but more often saw multiple abnormalities in patients with OPG. However, no pattern of configurational abnormality emerged. OPG is less frequent in African-Americans. Orbital volumetric disparity seems to be independent of the presence of OPG.

Entities:  

Mesh:

Year:  1998        PMID: 9719366      PMCID: PMC1051385          DOI: 10.1136/jmg.35.8.628

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  EFFECT OF RADIATION ON THE DEVELOPMENT OF FACIAL STRUCTURES IN RETINOBLASTOMA CASES.

Authors:  D M JU; M MOSS; G F CRIKELAIR
Journal:  Am J Surg       Date:  1963-11       Impact factor: 2.565

2.  THE EFFECT OF EARLY ENUCLEATION ON THE ORBIT; IN ANIMALS AND HUMANS.

Authors:  R E KENNEDY
Journal:  Am J Ophthalmol       Date:  1965-08       Impact factor: 5.258

3.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

4.  Effect of irradiation on facial growth: a 7- to 25-year follow-up.

Authors:  B Guyuron; A P Dagys; I R Munro; R B Ross
Journal:  Ann Plast Surg       Date:  1983-11       Impact factor: 1.539

5.  Cranial computed tomography in the phakomatoses.

Authors:  D Gardeur; A Palmieri; R Mashaly
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

6.  Cranial CT of neurofibromatosis.

Authors:  C G Jacoby; R T Go; R A Beren
Journal:  AJR Am J Roentgenol       Date:  1980-09       Impact factor: 3.959

7.  Orbital development in long-term survivors of retinoblastoma.

Authors:  S C Kaste; G Chen; J Fontanesi; D B Crom; C B Pratt
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

8.  Hypertelorism in neurofibromatosis.

Authors:  E C Wolters; W Westerhof; J W Delleman; P Dijkstra
Journal:  Neuropediatrics       Date:  1986-11       Impact factor: 1.947

9.  Analysis of skull anthropometric measurements in patients with neurofibromatosis type-1.

Authors:  F J DiMario; P Bowers; B Jagjivan; J Burleson; S Langshur; R M Greenstein
Journal:  Invest Radiol       Date:  1993-02       Impact factor: 6.016

10.  Orbital dysplasia in neurofibromatosis.

Authors:  E F Binet; S A Kieffer; S H Martin; H O Peterson
Journal:  Radiology       Date:  1969-10       Impact factor: 11.105

View more
  6 in total

1.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

2.  Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.

Authors:  Kimberly J Johnson; Nancy L Zoellner; David H Gutmann
Journal:  Cancer Epidemiol       Date:  2016-03-25       Impact factor: 2.984

3.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

4.  Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

Authors:  V M Park; E K Pivnick
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

5.  Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.

Authors:  Bree Porcelli; Nancy L Zoellner; Salmafatima S Abadin; David H Gutmann; Kimberly J Johnson
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

6.  Sphenoid Bone Pneumatisation on Lateral Cephalograms of Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Hannah T Scheuer; Jan F Kersten; Hanna A Scheuer
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.